CATX
Perspective Therapeutics Inc.
2.50$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -350.9% | – | +17.8% | +13.5% | -36.6% | +57.7% | -21.4% | -27.9% | -79.4% | +76.7% | +6.6% | – | |
| – | – | – | +70.3% | – | – | – | +9.6% | +5.7% | +30.5% | +11.4% | +0.0% | – | |
| – | -2,212.5% | – | -146.3% | – | – | – | – | – | – | – | – | – | |
| – | +7.6% | -12.0% | +39.2% | +61.4% | +7.1% | -11.8% | +7.2% | +67.1% | +61.9% | -38.5% | +6.4% | – | |
| – | -9.0% | +37.6% | -6.2% | +26.5% | +18.2% | -4.9% | -1.7% | +0.3% | -10.1% | +0.5% | +11.6% | – | |
| – | -77.9% | +282.4% | +32.2% | +43.6% | +141.4% | -59.2% | +28.7% | +15.7% | +45.9% | -31.6% | +7.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -14.3% | -41.7% | +107.1% | +137.9% | +5.8% | -5.5% | +72.5% | -45.4% | -1.5% | +64.1% | -32.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2,723.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.